Display options
Share it on

J Cell Commun Signal. 2009 Mar;3(1):65-77. doi: 10.1007/s12079-009-0054-6. Epub 2009 Apr 29.

Domain-and species-specific monoclonal antibodies recognize the Von Willebrand Factor-C domain of CCN5.

Journal of cell communication and signaling

Lan Wei, Frank McKeon, Joshua W Russo, Joan Lemire, John Castellot

Affiliations

  1. Department of Anatomy and Cellular Biology, Tufts University School of Medicine, 136 Harrison Avenue, Boston, MA, 02111, USA.

PMID: 19401828 PMCID: PMC2686757 DOI: 10.1007/s12079-009-0054-6

Abstract

The CCN family of proteins typically consists of four distinct peptide domains: an insulin-like growth factor binding protein-type (IGFBP) domain, a Von Willebrand Factor C (VWC) domain, a thrombospondin type 1 repeat (TSP1) domain, and a carboxy-terminal (CT) domain. The six family members participate in many processes, including proliferation, motility, cell-matrix signaling, angiogenesis, and wound healing. Accumulating evidence suggests that truncated and alternatively spliced isoforms are responsible for the diverse functions of CCN proteins in both normal and pathophysiologic states. Analysis of the properties and functions of individual CCN domains further corroborates this idea. CCN5 is unique among the CCN family members because it lacks the CT-domain. To dissect the domain functions of CCN5, we are developing domain-specific mouse monoclonal antibodies. Monoclonal antibodies have the advantages of great specificity, reproducibility, and ease of long-term storage and production. In this communication, we injected mixtures of GST-fused rat CCN5 domains into mice to generate monoclonal antibodies. To identify the domains recognized by the antibodies, we constructed serial expression plasmids that express dual-tagged rat CCN5 domains. All of the monoclonal antibodies generated to date recognize the VWC domain, indicating it is the most highly immunogenic of the CCN5 domains. We characterized one particular clone, 22H10, and found that it recognizes mouse and rat CCN5, but not human recombinant CCN5. Purified 22H10 was successfully applied in Western Blot analysis, immunofluorescence of cultured cells and tissues, and immunoprecipitation, indicating that it will be a useful tool for domain analysis and studies of mouse-human tumor models.

References

  1. J Cell Physiol. 2001 Jul;188(1):45-55 - PubMed
  2. Growth Factors. 1998;15(3):199-213 - PubMed
  3. Growth Factors. 2008 Apr;26(2):80-91 - PubMed
  4. Vitam Horm. 2005;70:69-103 - PubMed
  5. Int J Biochem Cell Biol. 2009 Apr;41(4):771-83 - PubMed
  6. J Biol Chem. 2004 Oct 15;279(42):44177-87 - PubMed
  7. Front Biosci. 2005 May 01;10:998-1009 - PubMed
  8. Biochem Biophys Res Commun. 1998 Oct 29;251(3):748-52 - PubMed
  9. J Biol Chem. 2004 Oct 15;279(42):44166-76 - PubMed
  10. Am J Pathol. 1998 Jun;152(6):1563-75 - PubMed
  11. Biochem Biophys Res Commun. 2001 Mar 30;282(2):421-5 - PubMed
  12. J Biol Chem. 1997 Aug 8;272(32):20275-82 - PubMed
  13. Mol Hum Reprod. 2004 Mar;10(3):181-7 - PubMed
  14. Am J Pathol. 2003 Jan;162(1):219-31 - PubMed
  15. Lancet. 2004 Jan 3;363(9402):62-4 - PubMed
  16. Biochem Biophys Res Commun. 2008 Apr 11;368(3):808-14 - PubMed
  17. J Cell Commun Signal. 2007 Sep;1(2):127-43 - PubMed
  18. Angiogenesis. 2007;10(1):1-11 - PubMed
  19. Cancer Res. 2008 Sep 15;68(18):7606-12 - PubMed
  20. J Biol Chem. 2003 Sep 5;278(36):33801-8 - PubMed
  21. J Cell Commun Signal. 2007 Sep;1(2):145-58 - PubMed
  22. Protein Expr Purif. 2008 Jun;59(2):242-8 - PubMed
  23. Cell Commun Signal. 2003 Nov 24;1(1):5 - PubMed
  24. Mol Cell Biol. 2005 Jan;25(1):414-21 - PubMed
  25. J Immunol Methods. 2009 Feb 28;341(1-2):19-29 - PubMed
  26. J Biochem. 2004 Mar;135(3):347-54 - PubMed
  27. Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14717-22 - PubMed
  28. Mol Cell Biol. 1998 Oct;18(10):6131-41 - PubMed
  29. Cell Growth Differ. 1991 Jul;2(7):351-7 - PubMed
  30. Virchows Arch. 2008 Jan;452(1):33-9 - PubMed
  31. J Cell Commun Signal. 2007 Sep;1(2):91-102 - PubMed
  32. Trends Biochem Sci. 2008 Oct;33(10):461-73 - PubMed
  33. Endocrinology. 2004 Feb;145(2):976-82 - PubMed

Publication Types

Grant support